Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ying-Jun Chang

Showing results (171-180 of 236) with videos related to

Pageof 24
Sort By:
Cellular & Molecular Immunology|January 7, 2021
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantationHuidong Guo, Ying-Jun Chang, Yan Hong, et al.
Frontiers in Oncology|August 8, 2022
Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab TreatmentDao-Xing Deng, Shuang Fan, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibodyYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Leukemia & Lymphoma|February 10, 2016
Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantationYing-Jun Chang, Hong-Tao Wang, Lan-Ping Xu, et al.
Frontiers in Immunology|February 14, 2022
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry StudiesMeng-Zhu Shen, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Bone Marrow Transplantation|August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Journal of Cellular Physiology|February 21, 2021
HCMV modulates c-Mpl/IEX-1 pathway-mediated megakaryo/thrombopoiesis via PDGFRα and αvβ3 receptors after allo-HSCTFei-Er Feng, Gao-Chao Zhang, Feng-Qi Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2018
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiationBrian C Betts, David Bastian, Supinya Iamsawat, et al.
Annals of Hematology|March 24, 2018
IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCTXiao-Hui Zhang, Xin Zhao, Chen-Cong Wang, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Pageof 24

Showing results (171-180 of 236) with videos related to

Sort By:
Pageof 24
Cellular & Molecular Immunology|January 7, 2021
Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantationHuidong Guo, Ying-Jun Chang, Yan Hong, et al.
Frontiers in Oncology|August 8, 2022
Immune Reconstitution of Patients Who Recovered From Steroid-Refractory Acute Graft-Versus-Host Disease After Basiliximab TreatmentDao-Xing Deng, Shuang Fan, Xiao-Hui Zhang, et al.
Bone Marrow Transplantation|May 10, 2020
Rituximab for desensitization during HLA-mismatched stem cell transplantation in patients with a positive donor-specific anti-HLA antibodyYing-Jun Chang, Lan-Ping Xu, Yu Wang, et al.
Leukemia & Lymphoma|February 10, 2016
Combined model of the EBMT score modified model and the HCT-CI improves the stratification of high-risk patients undergoing unmanipulated haploidentical blood and marrow transplantationYing-Jun Chang, Hong-Tao Wang, Lan-Ping Xu, et al.
Frontiers in Immunology|February 14, 2022
Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry StudiesMeng-Zhu Shen, Xiao-Hui Zhang, Lan-Ping Xu, et al.
Bone Marrow Transplantation|August 23, 2025
Leukemia stem cells for relapse prediction in AML patients receiving allografts: long-term follow-up of a prospective studySi-Qi Li, Lan-Ping Xu, Yu Wang, et al.
Journal of Cellular Physiology|February 21, 2021
HCMV modulates c-Mpl/IEX-1 pathway-mediated megakaryo/thrombopoiesis via PDGFRα and αvβ3 receptors after allo-HSCTFei-Er Feng, Gao-Chao Zhang, Feng-Qi Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2018
Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiationBrian C Betts, David Bastian, Supinya Iamsawat, et al.
Annals of Hematology|March 24, 2018
IgG synthesis rate and anti-myelin oligodendrocyte glycoprotein antibody in CSF may be associated with the onset of CNS demyelination after haplo-HSCTXiao-Hui Zhang, Xin Zhao, Chen-Cong Wang, et al.
Bone Marrow Transplantation|January 19, 2019
Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factorsMeng Lv, Shu-Zhen Zhai, Yu Wang, et al.
Pageof 24